Dr. Bradley is Professor of Surgery and Vice Chair of Obstetrics and Gynecology at the Women’s Health Institute, and Director, Center for Menstrual Disorders, Fibroids, and Hysteroscopic Services, Cleveland Clinic, Cleveland, Ohio. Dr. Bradley serves on the OBG MANAGEMENT Board of Editors.
Dr. Bradley reports that she has received research or grant support from and is a consultant and speaker for Bayer, is a speaker for Smith & Nephew and Teva, serves on the scientific advisory board for Boston Scientific, is a consultant to Karl Storz, and has received royalties from UpToDate and Elsevier.
Dr. Bradley comments on the new product labeling for Essure tubal implants, which now includes a boxed warning, and a patient-doctor discussion checklist that clinicians can use as a guide for conducting the critical conversation with patients about permanent sterilization
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel .